Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 4
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Changes in antimicrobial resistance and outcomes of health care-associated infections.
Aydın M, Azak E, Bilgin H, Menekse S, Asan A, Mert HTE, Yulugkural Z, Altunal LN, Hatipoğlu ÇA, Tuncer Ertem G, Altunok ES, Demirkaya MH, Çeviker SA, Akgul F, Memis Z, Konya P, Azap A, Aydin G, Korkmaz D, Karakoç ZÇ, Yapar D, Karakecili F, Gunal O, Keske S, Kapmaz M, Kader C, Demirel A, Ergönül Ö. Aydın M, et al. Among authors: altunal ln. Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1737-1742. doi: 10.1007/s10096-020-04140-y. Epub 2021 Feb 14. Eur J Clin Microbiol Infect Dis. 2021. PMID: 33586014
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls.
Mert A, Vahaboğlu H, Arslan F, Batirel A, Saraçoğlu KT, Bastug A, Çağatay A, Irmak İ, Dizman GT, Ertenli İ, Altunal LN, Sengel BE, Bayram M, Omma A, Amikishiyev S, Aypak A, Bes C, Bolukçu S, Içten S, Topeli A, Bektaş M, Arslan BY, Öztürk S, Çomoğlu Ş, Aydin S, Küçükşahin O, Içaçan OC, Ince B, Aghamuradov S, Mutlu MY, Şimşek F, Emre S, Ustun C, Ergen P, Aydin Ö, Koç MM, Sevindik ÖG, Odabaşı Z, Korten V, Bodur H, Güner R, Ünal S, Kocak M, Gül A. Mert A, et al. Among authors: altunal ln. Rheumatol Int. 2022 Mar;42(3):457-467. doi: 10.1007/s00296-021-04965-6. Epub 2021 Sep 13. Rheumatol Int. 2022. PMID: 34515808 Free PMC article.
Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial.
Omma A, Batirel A, Aydin M, Yilmaz Karadag F, Erden A, Kucuksahin O, Armagan B, Güven SC, Karakas O, Gokdemir S, Altunal LN, Buber AA, Gemcioglu E, Zengin O, Inan O, Sahiner ES, Korukluoglu G, Sezer Z, Ozdarendeli A, Kara A, Ates I. Omma A, et al. Among authors: altunal ln. Hum Vaccin Immunother. 2022 Nov 30;18(6):2122503. doi: 10.1080/21645515.2022.2122503. Epub 2022 Oct 31. Hum Vaccin Immunother. 2022. PMID: 36315843 Free PMC article. Clinical Trial.
Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.
Ates I, Batirel A, Aydin M, Karadag FY, Erden A, Kucuksahin O, Armagan B, Guven SC, Karakas O, Gokdemir S, Altunal LN, Buber AA, Gemcioglu E, Zengin O, Inan O, Sahiner ES, Korukluoglu G, Sezer Z, Ozdarendeli A, Omma A, Kara A. Ates I, et al. Among authors: altunal ln. Vaccines (Basel). 2023 Jul 12;11(7):1234. doi: 10.3390/vaccines11071234. Vaccines (Basel). 2023. PMID: 37515050 Free PMC article.
12 results